SCHEMBL14463524

SCHEMBL14463524

O=C1NC(=O)c2ccc(-n3ncc4ccccc43)c3cccc1c23

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ PARP1 P09874 2/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ USP2 O75604 2/20 0.44
▸ POLB P06746 2/20 0.44
▸ RGS12 O14924 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ APEX1 P27695 1/20 0.44
▸ CASP1 P29466 1/20 0.44
▸ BRCA1 P38398 1/20 0.44
▸ MTOR P42345 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ CASP7 P55210 1/20 0.44
▸ GNAI1 P63096 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23173777 0.76 PRKACA (0.54) MEN1KMT2APARP1NPSR1USP2
SCHEMBL2188830 0.74 CYP11B1 (0.48) MEN1KMT2APOLBCYP1A2MAPT
SCHEMBL24179211 0.72 ALDH1A1 (0.36) MEN1KMT2APOLBCYP1A2CASP1
SCHEMBL25839484 0.71 POLB (0.51) POLBMAPTKEAP1NFE2L2SMN1; SMN2
SCHEMBL28465394 0.70 MEN1 (0.56) MEN1KMT2APARP1NPSR1USP2
SCHEMBL28411756 0.69 MEN1 (0.54) MEN1KMT2APARP1NPSR1USP2
SCHEMBL14463520 0.69 MEN1 (0.57) MEN1KMT2APARP1NPSR1USP2
SCHEMBL19968134 0.68 CYP17A1 (0.57) MEN1KMT2ACYP1A2MGAMGAA
SCHEMBL3421714 0.68 MEN1 (0.59) MEN1KMT2APARP1NPSR1USP2
SCHEMBL14463495 0.67 CYP3A4 (0.48) MEN1KMT2APARP1NPSR1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007064345-A9 HETEROCYCLIC-SUBSTITUTED BIS-1,8 NAPHTHALIMIDE COMPOUNDS, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE GENENTECH INC (US) 2007-07-12 — — WO disclosed
Send feedback